Rosiglitazone or pioglitazone in type 2 diabetes?
de Vries, C. S. and Russell-Jones, D. L., 2009. Rosiglitazone or pioglitazone in type 2 diabetes? British Medical Journal, 339, b3076.
Related documents:This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below. (Contact Author)
|Creators||de Vries, C. S.and Russell-Jones, D. L.|
|Uncontrolled Keywords||risk, cardiovascular death, congestive-heart-failure, mortality, thiazolidinedione use|
|Departments||Faculty of Science > Pharmacy & Pharmacology|
Actions (login required)